Avisa Pharma, Inc. announced a commercially reasonable efforts brokered private placement of up to 10,937,500 subscription receipts at a price of $0.46 per subscription receipt for gross proceeds of $5,031,250 on May 12, 2020. The transaction is expected to close in June 2020.